138 results on '"Thomsen, Troels"'
Search Results
2. Real-world outcomes following third or subsequent lines of therapy:A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas
3. Real‐world outcomes following third or subsequent lines of therapy: A Danish population‐based study on 189 patients with relapsed/refractory large B‐cell lymphomas
4. Real‐world outcomes following third or subsequent lines of therapy: A Danish population‐based study on 189 patients with relapsed/refractory large B‐cell lymphomas.
5. Clinical Presentation and Outcome of Sinonasal Extraosseous Plasmacytoma in Denmark:A Nationwide Cohort From 1980 to 2017
6. Clinical Presentation and Outcome of Sinonasal Extraosseous Plasmacytoma in Denmark: A Nationwide Cohort From 1980 to 2017.
7. Clinical Presentation and Outcome of Sinonasal Extraosseous Plasmacytoma in Denmark: A Nationwide Cohort From 1980 to 2017
8. Outcome after 3rd Line Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study
9. Mucosal Delivery of RNAi Therapeutics
10. Impact of combined endometrial resection or ablation and levonorgestrel intrauterine device on postoperative bleeding pattern
11. NK- and T-cell lymphoma of the nasal cavity and paranasal sinuses in Denmark 1980-2017:a nationwide cohort study
12. Sinonasal B-cell lymphomas:A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B-cell lymphoma
13. NK- and T-cell lymphoma of the nasal cavity and paranasal sinuses in Denmark 1980–2017: a nationwide cohort study
14. sj-docx-1-aor-10.1177_00034894221139362 – Supplemental material for Clinical Presentation and Outcome of Sinonasal Extraosseous Plasmacytoma in Denmark: A Nationwide Cohort From 1980 to 2017
15. Sinonasal B‐cell lymphomas: A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B‐cell lymphoma
16. Evaluating the causal relevance of diverse risk markers: horizontal systematic review
17. Acceptance of the smoking cessation intervention in a large population-based study: The Inter99 study
18. Screening for risk of cardiovascular disease is not associated with mental distress: The Inter99 study
19. Clinical translation of RNAi-based treatments for respiratory diseases
20. Design and test of an office fitness application with the use of persuasive technologies
21. Mucosal Delivery of RNAi Therapeutics
22. Hyaluronic Acid Molecular Weight-Dependent Modulation of Mucin Nanostructure for Potential Mucosal Therapeutic Applications
23. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study
24. Avulsion of the occipital bone-an airbag-specific injury
25. Myocardial Sarcoidosis in Forensic Medicine
26. Hyaluronic Acid Molecular Weight-Dependent Modulation of Mucin Nanostructure for Potential Mucosal Therapeutic Applications
27. Additional file 1: of Partial nephrogenic diabetes insipidus caused by a novel AQP2 variation impairing trafficking of the aquaporin-2 water channel
28. The potential of chitosan-based siRNA nanocarriers for the oral treatment of Inflammatory Bowel Disease
29. Partial nephrogenic diabetes insipidus caused by a novel AQP2 variation impairing trafficking of the aquaporin-2 water channel
30. NBS SFI-begreber:rapport vedrørende begrebssystem og definitioner : 1.0/18. december 2012
31. Cardiovascular risk estimation in older persons: SCORE O.P.
32. Outcome after 3rdLine Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study
33. Mucus barrier-triggered disassembly of siRNA nanocarriers
34. Thomsen, Troels
35. Evaluating the causal relevance of diverse risk markers:horizontal systematic review
36. Evaluating the causal relevance of diverse risk markers: Horizontal systematic review
37. Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies
38. Cardiovascular risk estimation in older persons: SCORE O.P.
39. Clinical translation of RNAi-based treatments for respiratory diseases
40. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2)
41. HeartScore®: a new web-based approach to European cardiovascular disease risk management
42. The use of computerized decision support systems in preventive cardiology???principal results from the national PRECARD?? survey in Denmark
43. The Use of Computerized Decision Support Systems in Preventive Cardiology—Principal Results from the National Precard® Survey in Denmark
44. Resumen Ejecutivo: Guía Europea de Prevención Cardiovascular en la práctica clínica
45. European guidelines on cardiovascular disease prevention in clinical practiceThird Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
46. In vivo measurement of human body composition by dual-energy X-ray absorptiometry (DXA)
47. European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
48. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1)
49. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2)
50. Assessment of Coronary Risk in General Practice in Relation to the Use of Guidelines: A Survey in Denmark
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.